My Application Form Status

Check the status of your application form with Angel Broking.
  • Companies
  • Everything else
Search

CMP : 315Target Price : 385

TV Today Network (TTNL) reported a subdued set of numbers for 2QFY2017 with its consolidated top-line growing by ~5% yoy. On the operating front, the company reported margin contraction on account of higher selling & administrative expenses, which resulted in the de-growth of net profit by ~7% yoy. We expect TTNL to report a net reven..

View As PDF

CMP : 175Target Price : 265

Navkar Corporation (NCL) reported a subdued set of numbers for 2QFY2017. The consolidated top-line grew by ~5% yoy; while on the operating front, the company reported a margin contraction on account of prolonged monsoons that resulted in higher operational costs. The net profit grew by ~4% yoy due to lower subdued sales and poor operating..

View As PDF

Sort By

CMP : 175
Target Price : 265

Navkar Corporation (NCL) reported a subdued set of numbers for 2QFY2017. The consolidated top-line grew by ~5% yoy; while on the operating front, the company reported a margin contraction on account of prolonged monsoons that resulted in higher operational costs. The net profit grew by ~4% yoy due to lower subdued sales and poor operating..

Dec 01st 2016

Federal Bank Ltd

CMP : 71
Target Price : 85

In Q1FY17, the bank reported 19% loan growth, which further accelerated to 27% in Q2FY17, backed by 47% jump in corporate loan book. Retail loans also were strong. Gold loan, which had been under pressure and also saw degrowth in previous quarters, saw a comeback thus contributing to the growth. While the process of demonetization is like..

CMP : 148
Target Price : 174

Lakshmi Vilas Bank (LVB) is a south based private sector bank with major business (50.2%) concentrated in the state of Tamil Nadu. As of FY16, LVB has a network of 460 branches and 910 ATMs, with business size of Rs45,250cr. LVB has beefed up teams with lateral hiring from banks & NBFCs and implemented innovative large scale technolog..

CMP : 1,187
Target Price : 1,605

Siyaram Silk Mills (SSML)’ results for 2QFY2017 have come in below our estimates, both on top-line and bottom-line front, on back of lower volume growth due to weak consumer buying sentiments. Going forward, we expect SSML to report net sales CAGR of ~10% to ~Rs1,948cr and adj. net profit CAGR of ~11% to Rs107cr over FY2016-18E. The same ..

CMP : 683
Target Price : 847

Sun Pharma posted numbers better than expected on OPM and net profit front. Sales came in at Rs7,764cr vs. Rs7,800cr expected vs. Rs6,858cr in 2QFY2016, posting a yoy growth of 13.2%. On the operating front, the EBITDA margin came in at 34.3% vs. 30.1% expected and vs. 27.1% in 2QFY2016. Lower expenses during the quarter aided the OPM exp..

CMP : 80
Target Price : 107

We expect MIL to report a net revenue CAGR of ~9% to ~Rs1,106cr over FY2016-18E on back of strong growth in domestic branded sales (owing to aggressive ad spend and addition in the number of EBOs & multi-brand outlets [MBOs]) and healthy export revenues. On the bottom-line front, we expect a CAGR of ~9% to Rs92cr over the same period ..

CMP : 550
Target Price : 618

Going ahead, we expect GWRL to report a healthy topline in anticipation of strong domestic as well as export sales. On the domestic front, we expect demand to pick up with an expected growth in the agriculture and fisheries segments in the country. Further, we expect the company to continue reporting strong numbers on back of higher deman..

CMP : 540
Target Price : 613

Ipca Laboratories posted numbers lower than expected on the net profit and OPM front. On sales front, the company posted sales of Rs853cr (vs. Rs750cr expected vs. Rs739cr in 2QFY2016), posting a yoy growth of 15.5%. On the operating front, the EBITDA margin came in at 12.8% vs. 14.9% expected vs. 10.6% in 2QFY2016. Consequently, the Adj...

CMP : 733
Target Price : 877

Aurobindo Pharma (APL) posted numbers lower than expected on sales and net profit front, while OPM was more or less in line with expectations. On sales front, the company posted sales of Rs3715cr vs. Rs3,900cr expected vs. Rs3,280cr in 2QFY2016, posting a yoy growth of 13.3%. On the operating front, the EBITDA margin came in at 23.4% vs. ..

Nov 11th 2016

ICICI Bank Ltd

CMP : 277
Target Price : 315

ICICI Banks 2QFY17 results have been encouraging. While slippages remained high, large part of that came from the watch list. The bank has utilized part of the proceeds from stake sale in insurance business towards provisions. Management commentary also remained optimistic, as no addition is expected to the watch list; sharp deterioration..